Literature DB >> 25796520

Estimation of the success rate of anesthetic management for thymectomy in patients with myasthenia gravis treated without muscle relaxants: a retrospective observational cohort study.

Yoshihito Fujita1, Satoru Moriyama2, Satoshi Aoki3, Saya Yoshizawa3, Maiko Tomita3, Taiki Kojima3, Yukiko Mori3, Naoko Takeuchi3, Min-Hye So3, Motoki Yano2, Kazuya Sobue3.   

Abstract

Although maintaining anesthesia for myasthenia gravis (MG) with minimal muscle relaxants (MR) is common, the success rate of anesthetic management for MG without MR is not clear. We therefore retrospectively examined the success rate of anesthetic management for MG without MR among 66 consecutive cases of thymectomy for MG performed at our hospital between January 2004 and April 2010, before approval of using sugammadex. A total of 60 patients (90.9 %) were treated without MR (N group). Among the 60 cases, 17 (28.3 %) patients were not extubated in the operating room due to postoperative respiratory depression or other reasons. Therefore, the success rate of anesthetic management for thymectomy in patients with MG without treating MR was 71.7 % (43/60) [95 % confident interval (CI): 65.9-77.5 %]. The reasons for using MR included coughing at intubation in one case, bucking during surgery in two cases, and MR was considered to be safer by the attending anesthesiologist in three cases. The number of cases of impossible extubation requiring ventilation on that day was three in the N group and none in the R group. Finally, the success rate of anesthetic management for MG without MR was estimated to be 71.1 % (95 % CI: 65.9-77.5 %).

Entities:  

Keywords:  MG; Muscle relaxant; Myasthenia gravis; Thymectomy

Mesh:

Substances:

Year:  2015        PMID: 25796520     DOI: 10.1007/s00540-015-1999-7

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  9 in total

1.  Perioperative medical management and outcome following thymectomy for myasthenia gravis.

Authors:  C Chevalley; A Spiliopoulos; M de Perrot; J M Tschopp; M Licker
Journal:  Can J Anaesth       Date:  2001-05       Impact factor: 5.063

2.  Total intravenous anaesthesia with propofol for myasthenic patients.

Authors:  A Bouaggad; M A Bouderka; O Abassi
Journal:  Eur J Anaesthesiol       Date:  2005-05       Impact factor: 4.330

3.  Recurarization after sugammadex reversal in an obese patient.

Authors:  Frédérique Le Corre; Salmi Nejmeddine; Chérif Fatahine; Claude Tayar; Jean Marty; Benoît Plaud
Journal:  Can J Anaesth       Date:  2011-07-13       Impact factor: 5.063

4.  Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort.

Authors:  X Combes; L Andriamifidy; E Dufresne; P Suen; S Sauvat; E Scherrer; P Feiss; J Marty; P Duvaldestin
Journal:  Br J Anaesth       Date:  2007-06-15       Impact factor: 9.166

5.  Rocuronium in two myasthenic patients undergoing thymectomy.

Authors:  M Sanfilippo; G Fierro; M V Cavalletti; F Biancari; V Vilardi
Journal:  Acta Anaesthesiol Scand       Date:  1997-11       Impact factor: 2.105

6.  Laryngeal injuries and intubating conditions with or without muscular relaxation: an equivalence study.

Authors:  Lionel Bouvet; Alina Stoian; Sophie Jacquot-Laperrière; Bernard Allaouchiche; Dominique Chassard; Emmanuel Boselli
Journal:  Can J Anaesth       Date:  2008-10       Impact factor: 5.063

7.  Propofol or sevoflurane anesthesia without muscle relaxants allow the early extubation of myasthenic patients.

Authors:  Giorgio Della Rocca; Cecilia Coccia; Laura Diana; Livia Pompei; Maria G Costa; Eleonora Tomaselli; Pierangelo Di Marco; Vincenzo Vilardi; Paolo Pietropaoli
Journal:  Can J Anaesth       Date:  2003 Jun-Jul       Impact factor: 5.063

8.  The use of sugammadex in a patient with myasthenia gravis.

Authors:  C Unterbuchner; H Fink; M Blobner
Journal:  Anaesthesia       Date:  2010-01-23       Impact factor: 6.955

9.  Sensitivity to vecuronium in myasthenia gravis: a dose-response study.

Authors:  J B Eisenkraft; W J Book; A E Papatestas
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

  9 in total
  4 in total

Review 1.  [Deep neuromuscular blockade : Benefits and risks].

Authors:  C Unterbuchner; M Blobner
Journal:  Anaesthesist       Date:  2018-03       Impact factor: 1.041

2.  Sugammadex in the management of myasthenic patients undergoing surgery: beyond expectations.

Authors:  Michele Carron; Alessandro De Cassai; Federico Linassi
Journal:  Ann Transl Med       Date:  2019-12

3.  Magnesium sulfate reduces the rocuronium dose needed for satisfactory double lumen tube placement conditions in patients with myasthenia gravis.

Authors:  Shoujun Fei; Hengfu Xia; Xiaowei Chen; Dazhi Pang; Xuebing Xu
Journal:  BMC Anesthesiol       Date:  2019-08-31       Impact factor: 2.217

Review 4.  Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders-a scoping review.

Authors:  Luuk R van den Bersselaar; Madelief Gubbels; Sheila Riazi; Luc Heytens; Heinz Jungbluth; Nicol C Voermans; Marc M J Snoeck
Journal:  Can J Anaesth       Date:  2022-03-23       Impact factor: 6.713

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.